Search - tctmd.com

Displaying 101 - 120 of 229

Sort: Relevancy | Date

Presentation TCT 2017

Case Presentation: A High-Risk Patient With Complex Multivessel Disease PCI vs CABG?

Presenter: Issam D. Moussa, Emmanouil S. Brilakis

October 30, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

Presentation TCT 2017

CULPRIT-SHOCK: A Randomized Trial of Multivessel PCI in Cardiogenic Shock

Presenter: Gregg W. Stone, Holger Thiele

October 30, 2017

News Conference News TCT 2017

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Todd Neale

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing COMPLETE Trial Change the Current Recommended Approach to Multivessel Disease in STEMI?

Presenter: C. Michael Gibson, Stephan Windecker, David Hildick-Smith

October 30, 2017

Presentation TCT 2017

Case #5: Primary PCI in a Patient With Multivessel Disease

Presenter: Jose L. Leiva-Pons, Ricardo Quizhpe

October 29, 2017

Presentation TCT 2017

Case Presentation 3: Multivessel PCI

Presenter: Juan F. Granada, Roman Tarasov

October 29, 2017

Presentation TCT 2017

PCI Is More Than a Valid Alternative for Most Cases in Left Main and Multivessel Disease

Presenter: Gary S. Mintz, Seung-Jung Park

October 29, 2017

Presentation TCT 2017

Debate: Culprit Only and Deferred Revascularization in STEMI Should Be Routine

Presenter: Ran Kornowski, Mohamed Ahmed Sobhy, Guy Witberg

October 29, 2017

Presentation TCT 2017

Debate: Early Complete Revascularization in STEMI Should Be Routine

Presenter: Ran Kornowski, Mohamed Ahmed Sobhy, Mahmoud Idris Traina

October 29, 2017

Presentation TCT 2017

Case Presentation: A Patient With STEMI and Multivessel Disease

Presenter: Ran Kornowski, Mohamed Ahmed Sobhy, Owayed Al Shammeri

October 29, 2017

Presentation TCT 2017

Debate: STEMI With Multivessel Disease - Staged (Culprit) Lesion Revascularization Followed by Noninvasive Risk Stratification Is Currently Indicated

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Giulio G. Stefanini

October 29, 2017

Presentation TCT 2017

Debate: STEMI With Multivessel Disease - Immediate (or Early) Routine Complete Revascularization Is the Way to Go

Presenter: Jeroen J. Bax, Michael A. Borger, Stephan Windecker, Anthony H. Gershlick

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Conference News TCT 2016

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

Michael O'Riordan

November 02, 2016

Presentation TCT 2016

The Case for Multivessel PCI

Presenter: John A. Bittl, David J. Maron, Sripal Bangalore

November 01, 2016

News Conference News TCT 2016

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

Michael O'Riordan

November 01, 2016

Presentation TCT 2016

When There Are No Revascularization Options: Indications and Evidence for the Coronary Sinus Reducer in the CHIP Patient

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Gregg W. Stone

October 31, 2016

Presentation TCT 2016

How to Treat Diffuse Disease With Current PCI Devices

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Corrado Tamburino

October 31, 2016

Presentation TCT 2016

Managing the Post-Surgical and Surgical Turndown Patients: The Emerging Role of Complex PCI Strategies

Presenter: Jonathan M. Hill, Dimitri Karmpaliotis, Gennaro Sardella

October 31, 2016

Advertisement

Case Presentation: A High-Risk Patient With Complex Multivessel Disease PCI vs CABG?

Live From Denver: TCT 2017, Day One

CULPRIT-SHOCK: A Randomized Trial of Multivessel PCI in Cardiogenic Shock

CULPRIT-SHOCK Disputes Benefit of Immediate Multivessel PCI in Patients With Cardiogenic Shock

Predicting the Future: Will the Ongoing COMPLETE Trial Change the Current Recommended Approach to Multivessel Disease in STEMI?

Case #5: Primary PCI in a Patient With Multivessel Disease

Case Presentation 3: Multivessel PCI

PCI Is More Than a Valid Alternative for Most Cases in Left Main and Multivessel Disease

Debate: Culprit Only and Deferred Revascularization in STEMI Should Be Routine

Debate: Early Complete Revascularization in STEMI Should Be Routine

Case Presentation: A Patient With STEMI and Multivessel Disease

Debate: STEMI With Multivessel Disease - Staged (Culprit) Lesion Revascularization Followed by Noninvasive Risk Stratification Is Currently Indicated

Debate: STEMI With Multivessel Disease - Immediate (or Early) Routine Complete Revascularization Is the Way to Go

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

TRANSFORM-OCT: Similar Early and Late Healing With Bioresorbable- and Durable-Polymer DES

The Case for Multivessel PCI

ReACT: Routine Angiographic Follow-up After PCI Does Not Lower Clinical Events

When There Are No Revascularization Options: Indications and Evidence for the Coronary Sinus Reducer in the CHIP Patient

How to Treat Diffuse Disease With Current PCI Devices

Managing the Post-Surgical and Surgical Turndown Patients: The Emerging Role of Complex PCI Strategies

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content